Pharmaceuticals

Meeting the criteria: Registries as a source of regulatory-grade RWE

bexib
By bexib 0 Min Read

Peter Wahl, PhD, MLA, MS, Global Head of Scientific Operations at CorEvitas, a Thermo Fisher Scientific company, discusses key considerations when choosing a registry.

You Might Also Like

APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology

Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins

New ways to determine drug value with health equity in mind

Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions

Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer

Share This Article
Previous Article Current state of the housing market; mid-July 2024 overview
Next Article Did They Save the Bitcoin Market? – Investorempires.com
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Azzaro Group’s exciting new travel offering for 2025 combines the cultural hub of Cape Town with the unspoiled nature of the Okavango Delta
Hospitality & Tourism
Remaking history: Sarah Mather and Aquascope
Manufacturing
Christmas has arrived at Orelle – Luxury Hospitality Magazine
Hospitality & Tourism
A look inside: Allies developing a multicloud hybrid strategy
Banking